Two chemotherapy drugs combined with an agent that prevents the growth of blood vessels significantly delayed the spread of tumors in patients with metastatic melanoma.
Young adults with a short temper or mean disposition also tend to have compromised lung function, says a recent study published in the journal Health Psychology, by the American Psychological Association (APA).
As the largest coalition of U.S.-based nongovernmental organizations engaged in relief and development overseas, we applaud President Bush for demonstrating his renewed commitment to HIV/AIDS funding in developing countries by announcing his five-year, $30 billion AIDS plan.
Australian Health Minister Tony Abbott and Immigration Minister Kevin Andrews have advised Prime Minister John Howard to adopt a policy that would require HIV-positive migrants to report to health authorities within one month of arriving in Australia or risk losing their visas.
People who suffer from anxiety tend to interpret ambiguous situations, situations that could potentially be dangerous but not necessarily so, as threatening. Researchers from the Mouse Biology Unit of the European Molecular Biology Laboratory (EMBL) in Italy have now uncovered the neural basis for such anxiety behaviour in mice.
A drug described by some people as a “genius pill” for enhancing cognitive function provided relief to a small group of Rochester breast cancer survivors who were coping with a side effect known as “chemo-brain,” according to a University of Rochester Medical Center study.
China has opposed US FDA’s warning on toothpaste from China, and termed this irresponsible act on the part of US FDA, saying low levels of diethylene glycol (DEG) are not harmful.
A blood test that detects proteins commonly released by a growing tumor could one day become a useful tool for monitoring the effectiveness of chemotherapy and radiation treatment in people with advanced throat cancer, according to a study published in the June 1, 2007, issue of Clinical Cancer Research.
Januvia (scientific name sitagliptin), a new drug designed to improve blood sugar control in patients with type 2 diabetes, should not be used because the drug?s long-term safety is still unknown, Public Citizen writes in a new June posting on its WorstPills.org Web site.
CIGNA HealthCare President David Cordani to lead CIGNA employees in Cancer Challenge Ride; CIGNA to sponsor CIGNA-Calhoun Rider Zone